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Abstract
Background: Continuous exposure to tobacco smoke (TS) is a key cause of chronic obstructive
pulmonary disease (COPD), a complex multifactorial disease that is difficult to model in rodents.
The spontaneously hypertensive (SH) rat exhibits several COPD-associated co-morbidities such as
hypertension and increased coagulation. We have investigated whether SH rats are a more
appropriate animal paradigm of COPD.
Methods: SH rats were exposed to TS for 6 hours/day, 3 days/week for 14 weeks, and the lung
tissues examined by immunohistochemistry.
Results: TS induced a CK13-positive squamous metaplasia in proximal airways, which also stained
for Ki67 and p63. We hypothesise that this lesion arises by basal cell proliferation, which
differentiates to a squamous cell phenotype. Differences in staining profiles for the functional
markers CC10 and surfactant D, but not phospho-p38, indicated loss of ability to function
appropriately as secretory cells. Within the parenchyma, there were also differences in the staining
profiles for CC10 and surfactant D, indicating a possible attempt to compensate for losses in
proximal airways. In human COPD sections, areas of CK13-positive squamous metaplasia showed
sporadic p63 staining, suggesting that unlike the rat, this is not a basal cell-driven lesion.
Conclusion: This study demonstrates that although proximal airway metaplasia in rat and human
are both CK13+ and therefore squamous, they potentially arise by different mechanisms.
Background
Chronic obstructive pulmonary disease (COPD) is charac-
terised pathologically by loss of lung elasticity, airspace
enlargement, small airway remodelling and inflammation
[1]. It is widely acknowledged that tobacco smoke (TS) is
linked to the development of chronic obstructive pulmo-
nary disease (COPD) in humans. The epithelial mucosa of
the lung is the primary site of initial exposure to TS.
Repeated cycles of damage and repair to this mucosa in
response to chronic TS exposure can result in bronchial
epithelial squamous metaplasia, a histopathological fea-
ture of COPD, particularly in moderate to severe disease
Published: 24 November 2009
Respiratory Research 2009, 10:118 doi:10.1186/1465-9921-10-118
Received: 26 May 2009
Accepted: 24 November 2009
This article is available from: http://respiratory-research.com/content/10/1/118
© 2009 Bolton et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 15
(page number not for citation purposes)
Respiratory Research 2009, 10:118 http://respiratory-research.com/content/10/1/118[2,3]. Squamous metaplasia of the airways is seen as a
rapid repair mechanism akin to wound healing to main-
tain barrier integrity, that is reversible given appropriate
conditions, and mediates restitution of the normal airway
phenotype [4]. Normal pulmonary (bronchial) epithelial
repair mechanisms in response to injury involve the ded-
ifferentiation of epithelial cells to produce a squamous
cell covering that maintains mucosal integrity. The epithe-
lium is then repopulated via resident basal cell prolifera-
tion, which differentiate to form a new mature epithelial
barrier [5]. Repeated insults such as continued smoking,
or a delay in the differentiation and maturation of the epi-
thelium can result in squamous metaplasia that becomes
irreversible. Recent evidence by Araya and co-workers [6]
indicates that areas of squamous metaplasia are in com-
munication with the underlying mesenchyme, and via
activation of TGFβ, results in fibrosis and small airway
wall thickening. Thus, the presence of squamous metapla-
sia has important pathological consequences.
There are a variety of markers that reflect the particular sta-
tus or differentiated state of an epithelial cell. For exam-
ple, cytokeratins (CKs) have been widely used to
distinguish between different types of pulmonary epithe-
lial cells [7,8] and in humans are used to differentiate
between different types of lung carcinomas and sarcomas
[9]. There is a good level of homology between human
and rat CKs [10] and this has also been shown in rat bron-
chial carcinomas [11]. In particular, CK13 is a marker for
well-differentiated squamous cell carcinoma in rats and
humans. The transcription factor p63 is a homologue of
the p53 tumour suppressor protein and is considered as
reliable a marker of basal cells as high molecular weight
cytokeratins [12]. Factor p63 is proposed to be important
in the maintenance of epithelium stem cell populations
and is expressed on basal epithelial cells from many
organs including the lung [13,14]. Factor p63 exists in 2
alternatively transcribed isoforms: either a full length
transcript (transactivating or TAp63) or with deletion of
the TA domain (truncated or ΔNp63). The function of the
2 isoforms are different as TAp63 functions similar to p53
and promotes cell cycle arrest and apoptosis whereas the
ΔNp63 isoform is predominantly expressed in prolifera-
tive epithelial stem cell populations and can inhibit the
p53-like functions of p63TA. The ΔNp63 isoform shows
homology with a number of recently identified transcrip-
tion factors that are all specifically expressed in squamous
cell carcinomas [15-17]. Thus, ΔNp63 appears to play a
key role in the development of a squamous cell pheno-
type.
Rodent bronchial epithelial cells have a very rapid turno-
ver rates compared to humans and therefore lesions tend
to resolve quickly and spontaneous squamous metaplasia
is rare in rodents [18]. Squamous metaplasia can be
induced in rodents in response to various agents such as
TS [19], dioxins [20] or mineral dusts [21], although
bronchial neoplasias are difficult to induce as most of the
pathology occurs more peripherally within the lung
parenchyma. Recently, Zhong and co-workers [22]
described the presence of squamous metaplasia in the
proximal airways following chronic TS exposure in spon-
taneously hypertensive (SH) rats. These SH rats are known
to be more susceptible to airway disease compared to
non-SH rats [23]. For example, when SH rats are exposed
to sulphur dioxide for 5 days, they develop bronchitis that
is characterised by a neutrophilic inflammation and
mucus hypersecretion [24]. Also, acute exposure to TS will
induce a more robust inflammatory infiltrate compared to
Wistar-Kyoto rats [25]. SH rats are known to share some
key underlying pathologies with human COPD including
borderline hypertension, a hypercoagulative state and oxi-
dative stress [23,24]. SH rats have a defective CD36 scav-
enger receptor [26], but the role for this in respiratory
processes is unclear. There is now an accumulating body
of data that suggest that the SH rat, due to its shared phys-
iological characteristics with COPD patients, is a more
appropriate strain of rat in which to model airway disease.
In this study, we describe the phenotype of the epithelial
response in the lung to chronic TS exposure in SH rats. We
have examined, using an immunohistochemical
approach, the molecular profile of the epithelial cells in
both the proximal (bronchi and bronchioles) and distal
(respiratory bronchioles) airways and within the alveolar
bed. We have also compared the p63 profile seen in the TS
exposed rats with samples from human COPD lung and
the data suggest that despite morphological similarities,
squamous metaplasia arises via different mechanisms in
humans and rodents following chronic TS exposure.
Methods
Antibodies and reagents
See Table 1 for details of antibodies and their detection
systems. All other reagents were of analytical grade.
Exposure of rats to TS and necropsy
The rat lung sections used in this study were taken from
rats as described previously [22]. Briefly, 12 week old SH
rats (260-310 g) were purchased from Charles River Lab-
oratories (Raleigh, NC, USA) and allowed to acclimatise
for 1 week. They were maintained on a 12 hour light/dark
cycle and provided with water and rat chow ad libitum.
Animals were handled in accordance with standards
established by the US Animal Welfare Acts as set forth in
the National Institutes of Health guidelines and by the
University of California, Davis, Animal Care and Use
Committee. Rats were exposed to a mixture of main-
stream and sidestream smoke from humidified 1R4F cig-
arettes (Tobacco Health Research Institute, Lexington, KY,Page 2 of 15
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cigarettes under Federal Trade Commission conditions
(35 ml/puff, 2s duration, 1 puff/min). The smoke was col-
lected via a chimney and delivered to whole body cham-
bers. The animals were exposed to either filtered air (FA)
or high concentrations of TS (80 mg/m3) for 6 h/day, 3
days/week for either 7 or 14 weeks. At necropsy, each ani-
mal was given an overdose of sodium pentobarbital. The
trachea was cannulated and the left lung lobe was infla-
tion-fixed by intra-tracheal instillation of 4% buffered
zinc formalin (Z-fix) at 30 cm water pressure for 1 hr and
stored in 70% ethanol before processing. Transverse slices
were taken immediately cranial and caudal to the hilum
of the lobe, dehydrated in a graded ethanol series and
embedded in paraffin wax.
Human subjects and tissue
Human lung samples were obtained with written
informed consent from patients undergoing lung volume
reduction surgery at the Glenfield Hospital, Leicester.
Patients (GOLD4) were selected according to the inclu-
sion criteria described previously [27]. Tissue was fixed in
10% neutral buffered formalin (NBF) within 2-3 hours of
surgery, and was fixed for a further 48 hours in 10% NBF.
The tissue was embedded in paraffin using standard pro-
cedures. Fourteen blocks from 8 different patients were
used in this evaluation.
Immunohistochemistry
Sections from rats (5 per group) exposed to either FA or
high concentration of TS (80 mg/m3) were used in this
study as previously described [22]. 5 μm sections were cut
on a microtome and picked up on charged slides and
dried overnight at 37°C. Sections were dewaxed in xylene,
taken through graded alcohols into water. For staining
with haematoxylin and eosin (H&E), sections were
stained with Gills II haematoxylin (Pioneer Research
Chemicals, Colchester, Essex, UK) and eosin Y (Acros
Organics, Fisher Scientific, Loughborough, Leicestershire,
UK) on a Leica ST5020 Autostainer (Leica Microsystems,
Milton Keynes, Buckinghamshire, UK). Antigen retrieval
was performed as detailed in Table 1. Heat treatment was
by microwave (98°C, 5 mins, RHS-2 rapid Microwave
Histoprocessor, Milestone Srl, Sorisole, Italy) or pressure
cooker (Prestige, 15l bs, 2 mins). Sodium citrate buffer
was prepared to pH6 and Vector Unmasking Fluid (Vector
Labs, Peterborough, Cambs, UK) was used according to
manufacturer's instructions. Boric acid retrieval has been
described before [28]: sections are incubated in 0.1 M
boric acid, 60°C for 16 hrs. All steps were carried out
using a LabVision Autostainer except for incubation in the
chromogen diaminobenzidene (DAB). Bound antibody
was detected using either standard Streptavidin-Biotin
complex protocols (StreptABComplex, Dako), TSA ampli-
fication kit (Perkin Elmer) or Envision polymer technol-
Table 1: Antibodies used to characterise the epithelial response to TS in SH rats.
Antigen Source Catalogue No. Clone and Isotype Conc, μg/ml Antigen Retrieval Detection System
Caspase 3, activated Cell Signalling 9661 Rabbit IgG 1.0 MW, citrate StreptABC HRP, DAB
CC10 Cell Signalling 07-623 Rabbit IgG 1.0 MW, VUF StreptABC HRP, DAB
CD31 Serotec MCA1334G TLD-3A12, IgG1 6.67 BA TSA kit, HRP, DAB
Ki67 Vector VP-K452 MM1, IgG1 0.5 PC, VUF TSA kit, HRP, DAB
CK13 Chemicon CBL176 Ks13.1, IgG1 0.5 PC, VUF Envision HRP, DAB
Pan CK 
(4,5,6,8,10,13,18)
Chemicon Mab 1636 C11, IgG1 5.0 MW, VUF StreptABC HRP, DAB
p40 Calbiochem PC373 Rabbit IgG 1/2000 diln MW, citrate StreptABC HRP, DAB
p63 Pharmingen 559951 4A4, IgG1 5 None StreptABC HRP, DAB
Phospho-p38 Santa Cruz 17852 Rabbit IgG 1 None TSA kit, HRP, DAB
Surfactant D Abcam AB15687 SPDE, IgG2b 5 PC, VUF TSA kit, HRP, DAB
MW = Microwave; PC = pressure cook; BA = 0.2 M boric acid, pH7.0, 60°C 16-18 hours;VUF = Vector Unmasking Fluid (citrate = 0.01 M Na 
citrate, pH6.0);
StreptABC kit from Dako, used according to manufacturer's instructions; TSA kit from Perkin Elmer, used according to manufacturer's instructions; 
HRP HorseRadish Peroxidase; DAB = diaminobenzidine.Page 3 of 15
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Table 1). Sections were then counterstained in Gills II
Haematoxylin, dehydrated and mounted in DPX mount-
ing medium (Merck, Lutterworth, Leicestershire, UK).
Results
Morphology of TS induced changes in proximal and distal 
airways of SH rats
Rats exposed to FA for 7 or 14 weeks showed minimal
changes, mainly rarefaction of epithelial cell cytoplasm
and sporadic hypertrophy (Fig. 1A). Exposure to high con-
centrations of TS (80 mg/m3), led to the induction of a
squamous metaplasia in the proximal airway (bronchi
and bronchioles) at 7 and 14 weeks as has been described
previously [22]. At 7 weeks, the normal respiratory epithe-
lium was replaced by metaplastic squamous epithelial
cells with occasional stratification (Fig. 1B). By 14 weeks
the entire proximal airway was composed of stratified,
keratinizing squamous epithelial cells (Fig. 1C). Com-
pared to the FA controls (Fig. 1D), the smaller distal air-
ways (respiratory bronchioles) showed epithelial
hypertrophy and hyperplasia at 7 weeks (Fig 1E) After 14
weeks exposure, most distal airways were hyperplastic but
in three out of five rats, there were occasional airways
showing squamous metaplasia, although this was not as
advanced as in the proximal airways and was largely com-
posed of just 1 or 2 layers of cells (Fig. 1F).
Morphology of TS induced changes in the lung 
parenchyma of SH rats
Rats exposed to FA for 7 or 14 weeks showed minimal
changes, mainly a low-grade alveolitis (Fig. 2), including
fibrinoid microvascular leakage (Fig. 2A, arrows). Follow-
ing TS exposure, changes seen in the parenchyma at 7
weeks appeared to progress in severity and incidence by
14 weeks. At 7 weeks, there was a macrophagic inflamma-
tion including the presence of foam cells in the alveolar
bed and perivascular/peribronchiolar leucocytes (Fig. 2B,
arrow). The inflammation was reduced at 14 weeks but
there were now signs of type II pneumocyte proliferation
and remodelling of the parenchyma including mesenchy-
mal expansion of the alveolar walls and perivascular
regions typical of fibrosis (Fig. 2C, arrows). In addition,
there was evidence of remodelling (cast formation) of the
microvasculature in the alveolar bed (Fig. 2C inset,
arrows), hyperinflation and enlarged airspaces, as well as
loss of connectivity within the parenchyma (Fig. 2D, aster-
isk).
Cell turnover following TS exposure in SH rats
In order to investigate the balance between cell prolifera-
tion and cell death via apoptosis, sections were immunos-
tained with either anti-Ki67 antibodies (proliferation) or
anti-activated caspase 3 antibodies (apoptosis). In FA
exposed rats, staining for Ki67 was sporadic showing occa-
sional nuclear staining throughout all compartments of
the lung at both 7 and 14 weeks (data not shown). In the
TS exposed rats, within the area of squamous metaplasia,
all of the cell nuclei were positive for Ki67 regardless of
the site or time of exposure (Fig. 3A, proximal airway; Fig.
3B, distal airway, both 14 weeks). Within the smaller non-
metaplastic bronchioles there was an apparent increased
incidence of staining in epithelial cells following TS expo-
sure (data not shown). In TS exposed rats, Ki67 staining
was seen in the parenchyma, particularly of cells judged
on their morphology to be type II pneumocytes (Fig. 3C,
14 weeks). There appeared to be fewer numbers of cells
staining in the FA exposed rats (Fig. 3D).
Previously, Zhong et al., have documented the presence of
TUNEL-positive apoptotic cells in proximal, distal and
parenchymal cells in the same model and shown increases
in the numbers of TUNEL-positive cells in main proximal
and distal bronchioles but not in the parenchyma [29].
Using an anti-activated caspase 3 antibody, we found only
sporadic staining within the airway epithelial cells of
either the proximal or distal airways (data not shown).
However, staining was more apparent within the paren-
chyma, particularly in the nucleus of cells with a morphol-
ogy typical of Type II pneumocytes, following TS exposure
at both time points (Fig. 3E, 14 weeks, arrowheads). The
data indicated a slight increase that was more apparent at
7 weeks. Caspase 3 staining was also seen in vesicles typi-
cal of the lysosomal compartment of alveolar macro-
phages (Fig. 3F, arrows).
Epithelial profile of TS induced squamous metaplasia in 
proximal airways
We used antibodies to generate a molecular profile of the
epithelial cells following TS exposure. An anti-pan CK
(which recognises CKs 4, 5, 6, 8, 10, 13, 18) was used to
highlight all epithelial cells. Epithelial cells in all airways,
regardless of treatment, were positively stained (Fig. 4A,
FA, 14 weeks). The squamous metaplasia seen at either 7
or 14 weeks was very strongly stained (Fig. 4B, TS, 14
weeks). In addition to the airways, sporadic cells within
the alveolar bed were positively stained and, from their
morphology, were presumed to be type II pneumocytes
(data not shown). CK13 was used to highlight the mature
squamous epithelial in the areas of metaplasia. There was
no staining in FA exposed rats as expected (data not
shown) but after 7 weeks TS exposure, there was sporadic
staining in the proximal airways (Fig. 4C) but by 14
weeks, cells in the parabasal or superficial layers of the
squamous metaplasia were strongly positive (Fig. 4D).
Factor p63 is a marker of basal epithelial cells and nor-
mally shows nuclear staining of flattened basal cells (Fig.
4E, arrow). Following TS exposure, there was a marked
increase in the numbers of positive cells in proximal air-
ways in areas of squamous metaplasia. Staining was
restricted to nuclei of the basal and parabasal cells where
it showed a graded intensity, which decreased with dis-Page 4 of 15
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Morphology of TS induced changes in proximal and distal airways of SH ratsFigure 1
Morphology of TS induced changes in proximal and distal airways of SH rats. H&E stain for pathological assessment. 
Morphological changes were seen in proximal (A-C) and distal airways (D-F) following TS exposure. FA exposed rats showed 
minimal changes to proximal (A) and distal (D) airways. Exposure to TS for 7 (B) and 14 (C) weeks induced a squamous meta-
plasia in proximal airways (see high power inset in panel C). Distal airways showed epithelial hypertrophy at 7 weeks (E) but 
progressed to squamous metaplasia in occasional airways by 14 weeks (F). Magnification bar in F applies to panels A, B, D-F.
Respiratory Research 2009, 10:118 http://respiratory-research.com/content/10/1/118tance away from the basement membrane (Fig. 4F, 14
weeks). Staining was also seen in the acellular keratotic
layer of the metaplasia but the reason for this is unclear as
an isotype control incubated section did not show this
staining pattern (Fig. 4G). No staining was seen in the
smaller distal airways without pathology or the paren-
chyma. We further investigated the role of p63 by immu-
nostaining for the ΔNp63 truncated isoform using the p40
antibody [15]. Staining was identical to the p63 pattern
and was restricted to the nuclei of basal and parabasal
cells of the squamous metaplasia (data not shown).
Association of functional markers with squamous 
metaplasia in proximal and distal airways
We investigated whether the conversion of normal respi-
ratory epithelium to squamous epithelial cells would alter
the profile of some functional markers. We used CC10 as
a marker for Clara cells, which are known to respond to
inhaled toxicants [30-32] and has been proposed as a
peripheral biomarker of airway disease. We have previ-
ously shown that expression of CC10 and surfactant pro-
tein D (SP-D, expressed in Clara cells and a marker of type
II pneumocytes) can be induced in previously negative
Morphology of TS induced changes in the lung parenchyma of SH ratsFigure 2
Morphology of TS induced changes in the lung parenchyma of SH rats. H&E stain for pathological assessment. FA 
exposed rats showed fibrinoid leakage from the alveolar bed (A, arrows) but minimal changes to resident cells. Following TS 
exposure for 14 week, there was evidence of an inflammatory infiltrate within perivascular/peribronchiolar regions (B, arrow). 
There was also fibrosis of blood vessels and the alveolar bed (C, arrows). Casts of the alveolar capillaries (C, inset, arrows) 
indicated remodelling of the microvascular network. Loss of connectivity was also seen (D, asterisks) within the alveolar bed.Page 6 of 15
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Cellular turnover following TS exposure in SH ratsFigure 3
Cellular turnover following TS exposure in SH rats. Antibodies to Ki67 (A-D) and cleaved caspase 3 (E, F) were used to 
determine the level of cell turnover following TS exposure. Areas of squamous metaplasia in both proximal (A) and distal (B) 
airways were strongly and extensively stained for Ki67 compared to FA controls (data not shown). Within the alveolar bed, 
the numbers of cells staining for Ki67 was increased after TS exposure (C) compared to the FA controls (D). Staining for 
cleaved capsase 3 showed a marginal increase in the numbers of cells staining following TS exposure (E, arrowheads) compared 
to FA controls (F, arrowhead). Staining was also seen in vesicles of alveolar macrophages (F, arrows). Magnification bar in B 
applies to panels A and B. Magnification bar in E applies to panels C-E.
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Epithelial profile of TS induced squamous metaplasia in proximal airwaysFigure 4
Epithelial profile of TS induced squamous metaplasia in proximal airways. Antibodies against pan CK (A, B), CK13 
(C, D) and p63 (E, F, G) were used to characterise the squamous metaplastia seen in proximal airways following TS exposure. 
All epithelial cells were positive for panCK (A, B). After 7 weeks TS exposure, there was sporadic staining in areas of squamous 
metaplasia (C) but after 14 weeks, TS exposed rats showed CK13-positive staining in suprabasal regions of the entire airway 
(D). Staining for p63 highlighted sporadic basal stem cells in FA exposed rats (E, arrow). After 14 weeks of TS exposure in 
larger airways, all cell nuclei in areas of squamous metaplasia (F) were stained but with a gradation of intensity from the basal 
cells (intense) to the suprabasal cells (weak). Staining with the isotype control antibody (G) showed no specific nuclear staining 
although there was weak background staining in the cytoplasm.
Respiratory Research 2009, 10:118 http://respiratory-research.com/content/10/1/118cell types within the alveolar bed in response to an inflam-
matory stimulus, reflecting a possible change in function
[33]. We therefore were interested in these proteins as sen-
sitive markers of toxicity in the lung and whether they
would be altered after TS exposure. The involvement of
p38 as a key signalling mediator in the response to TS has
been examined previously in this model [22,34] and p-
p38 was considered a suitable marker to reflect the signal-
ling activity of the cells involved.
We looked at the expression of CC10, p-p38 and SP-D as
markers of epithelial function. CC10 staining was
observed in the cytoplasm of Clara cells in all sizes of air-
ways in FA exposed rats (see Fig. 5A for an example). This
staining was lost in the squamous epithelium following
14 weeks TS exposure (Fig. 6A, distal airways, arrow. Inset
shows proximal airways) but not from contiguous non-
squamous epithelium (Fig. 6A, arrowhead). The non-
squamous epithelium that was adjacent to the squamous
epithelium showed similar staining patterns to the FA
control rats (data not shown). In contrast, p-p38 was
detected in the cytoplasm of both non-squamous epithe-
lium (Fig. 6B, arrow) and squamous metaplasia cells (Fig.
6B, arrowhead and inset). Antibodies to SP-D appeared to
stain weakly squamous metaplasia found in the proximal
airways (Fig. 6C, inset), and the less stratified squamous
metaplasia found in the distal airways (Fig. 6C, arrow). In
non-squamous epithelium that was adjacent to the squa-
mous epithelium(Fig. 6C, arrowhead), the staining pat-
tern was similar to FA exposed rats (data not shown).
Molecular profile of functional markers in the lung 
parenchyma following TS exposure
Following TS exposure, the parenchyma showed focal
accumulations of inflammatory cells, particularly alveolar
macrophages and foam cells in conjunction other changes
to the alveolar bed (see Fig. 2A-D). Anti-CC10 antibodies
were seen to stain type II pneumocytes in FA exposed rats
(Fig. 5A). After TS exposure there were increased numbers
of cells staining due to the increased cellularity within the
alveolar bed (Fig. 2B). Anti-p-p38 antibodies were seen to
stain alveolar macrophages and occasional type II pneu-
mocytes in FA exposed rats (Fig. 5C). After TS exposure,
the staining appeared more diffuse due to increased cellu-
larity and type I pneumocytes also appeared to be staining
positive along with alveolar macrophages and type II
pneumocytes (Fig. 5D). Similar to p-p38, anti-SP-D anti-
bodies were seen to stain type II pneumocytes and alveo-
lar macrophages in FA exposed rats (Fig. 5E) and the
staining pattern after TS exposure was much more diffuse
with additional type I pneumocytes showing positive
staining (Fig. 5F). In all 3 cases, the staining pattern after
TS exposure was more diffuse due to the increased cellu-
larity of the alveolar bed. The microvasculature within the
alveolar bed appeared undamaged as assessed by anti-
CD31 staining (data not shown).
Comparison of squamous metaplasia in human COPD and 
TS exposed SH rat lungs
A comparison was made of the CK13 and the p63 profile
in areas of squamous metaplasia from human COPD lung
and TS exposed SH rat lungs. In human COPD lung, the
areas of squamous metaplasia within the airway were
focal, and unlike the rats in this study, it rarely encom-
passed the entire airway. For control purposes, airways
with squamous metaplasia were compared with non-
squamous airways from the same section (Fig. 7A, con-
trol). In humans, p63 is present in basal cells regardless of
airway size (Fig. 7A, arrow). This is in contrast to the SH
rats used in this study where, in non-squamous regions,
p63-positive basal cells were only seen in the largest air-
ways (Fig. 7B, arrow). Areas of squamous metaplasia were
characterised by positive CK13 staining in both the
human COPD tissue (Fig. 7C) and the TS exposed SH rats
(Fig. 7D). This staining was largely confined to the para-
basal and superficial layers of the squamous cells
although in the human tissue, some staining was occa-
sionally also seen in the most basal layer. In a marked
contrast, the p63 staining in human squamous metaplasia
highlighted sporadic cell nuclei scattered throughout the
basal and parabasal layers (Fig. 7E), whereas the TS
exposed SH rats, p63 staining was seen in all basal cells
and in most parabasal cells in the region of metaplasia
with a graded intensity the decreased away from the base-
ment membrane (Fig. 7F).
Discussion
COPD is a multi-factorial disease and existing animal
models involving a single insult in an otherwise healthy
animal are therefore limited in providing analogous
experimental pathology. Based on our observations, the
development and use of more complex, polygenic models
such as the SH rat is likely to provide a more relevant
model of human COPD. The similarities of the SH rat
model with COPD are two fold. Firstly, the squamous
metaplasia is found in the larger, more proximal airways
of the SH rats exposed to TS, which is a similar anatomical
location to human COPD lungs [3,35]. Secondly, the SH
rats show borderline hypertension like many COPD
patients although the mechanisms may differ [36]. Non-
SH rats subject to chronic regimes of TS do not develop
this pathology [19,37] indicating that the hypertensive
nature of the rat is contributing to the development of the
squamous metaplasia. Although our results indicate that
the common pathology may arise via a different mecha-
nism, and this may just be a reflection of inherent differ-
ences between rat and human, there is still considerable
value in the utility of this rat stain for respiratory research.
The SH rat is known to be susceptible to various inhaled
toxicants such as sulphur dioxide [24] or residual oil fly
ash [37] but the exact physiological reason for this is not
fully understood. It is known that these rats have a defect
in CD36, which leads to defects in fatty acid metabolismPage 9 of 15
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Molecular profile of functional markers in the lung parenchyma of TS induced SH ratsFigure 5
Molecular profile of functional markers in the lung parenchyma of TS induced SH rats. CC10 (A, B), p-p38 (C, D) 
and SP-D (E, F) expression were examined in the lung parenchyma after FA (A, C, E) and TS (B, D, F) exposure. After FA expo-
sure, CC10 was only seen in the parenchyma in occasional alveolar macrophages and type II pneumocytes. The image shown in 
A includes a transitional airway to demonstrate normal Clara cell staining. After TS exposure, CC10 was now seen more dif-
fusely in the alveolar bed in type II cells and alveolar macrophages (B). p-p38 (C) and SP-D (E) were observed in macrophages 
and type II pneumocytes within the alveolar bed in FA exposed SH rats and staining pattern appeared more extensive after TS 
exposure and included type I pneumocytes (D, F).
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Association of functional markers with squamous metaplasia in distal airwaysFigure 6
Association of functional markers with squamous metaplasia in distal airways. Antibodies against CC10 (A), p-p38 
(B) and SP-D (C) were used to assess the effect of squamous metaplasia on epithelial cell functional markers. Within distal air-
ways, there were areas of squamous metaplasia (arrow) contiguous with areas of non-squamous epithelial cells (arrowhead). 
CC10 (A) was lost from areas of squamous metaplasia (A, arrow), including the proximal airways (inset) but not from other 
areas of non-squamous airways (A, arrowhead). p-p38 (B, distal airway) was detected in all epithelial cells regardless of cell type 
including squamous metaplasia in the proximal airways (inset). SP-D (C) was lost from squamous regions in distal (C, arrow) 
and proximal airways (C, inset). In areas of non-squamous epithelium in the distal airways, epithelial cells were seen to stain 
positive (C, arrowhead).
Respiratory Research 2009, 10:118 http://respiratory-research.com/content/10/1/118but does not affect the hypertension [26], but the exact
impact this reduction in CD36 has on respiratory function
is not yet known. SH rats also show an increased inflam-
matory response and mucus production following sul-
phur dioxide exposure compared to Sprague-Dawley rats
and this may reflect how a compromised immune func-
tion can contribute to susceptibility to airway disease [24].
In addition to the borderline hypertension, the pulmo-
nary vascular bed is known to be compromised in SH rats
[37] and consistent with this, we found that microvascular
leakage was prominent following TS exposure but the cap-
illary bed still appeared patent as judged by CD31 stain-
ing. Another consequence of hypertension is hypoxia but
this has not been explored in this model. It is likely that
raised alveolar bed pressure could lead to local and
regional hypoxia that also affects the larger airways via
perturbation of the microvascular plexus that supplies the
larger vessels and bronchioles. Further studies would be
needed to investigate the contribution of hypoxia to the
increased susceptibility and development of airways dis-
ease of the SH rat.
The squamous metaplasia appears to progress down the
tracheobronchial tree with time and we have not been
able to establish the mechanism behind this. There are
two possible explanations. It could be due to the patho-
logical changes spreading down the airways from an ini-
tial site of origin within the proximal airways.
Comparison of squamous metaplasia in human COPD and TS exposed SH rat lungsFigure 7
Comparison of squamous metaplasia in human COPD and TS exposed SH rat lungs. Squamous metaplasia was 
identified in human COPD lung tissue (C, E) and 14 week TS exposed SH rat lungs (D, F) and compared to either non-squa-
mous airways in COPD lung (A) or FA exposed SH rats (B). They were stained for p63 (A, B, E, F) and CK13 (C, D). In the 
control non-squamous airways from both human (A) and rat (B), p63 stained occasional flattened cells close to the basement 
matrix of proximal airways. Areas of squamous metaplasia were identified in both human (C) and rat (D) tissue by CK13 stain-
ing. In contrast to the extensive p63 staining seen in the rat tissue (F), the human tissue showed only sporadic cells scattered 
through out the squamous metaplasia (E).Page 12 of 15
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tion and development times between proximal and distal
airways i.e. the pathology just takes longer to develop in
bronchioles rather than bronchi. The profiles seen with
CK13 (mature squamous cell marker), p63 (basal cell
marker) and Ki-67 (proliferative marker) indicate that the
squamous metaplasia is arising from the p63+, CK13-
basal cells that proliferate and mature to form a CK13+
p63- barrier of squamous epithelium. The graded inten-
sity of the p63 staining seen in the airways (Fig. 4F, strong-
est in cells closest to the basement membrane) could be
reflection of the gradual loss of this basal marker as the
epithelium matures. We chose these markers for our
immunohistochemistry studies as western blot studies on
whole lung homogenate from the same rats by Zhong and
co-workers [22] have already shown that there was an
increase CK5 (basal cell marker), which correlates with
our p63 finding. Interestingly, the authors found there
was a decrease in the markers of late epithelial maturation
- loricrin, involucrin and filaggrin. This, coupled with our
observation of an increase in CK13 indicates that the basal
cells are maturing to a squamous epithelium but do not
express markers of the terminally differentiated, mature
epithelium. CK13 staining has also been shown to corre-
late with well-differentiated squamous cell metaplasia in
human tissue [9,38]. The situation in rat is less clear where
Kal and co-workers [11] showed CK13 reactivity in 1 out
of 3 well differentiated squamous cell carcinomas. The CK
profiles have also been examined in the upper and lower
respiratory tract following TS exposure (Wistar rats, 12
hrs/day, 5 days/week, 8 weeks) but found neither patho-
logical changes in the lungs nor any CK13 reactivity [39].
However, their data were generated in Wistar rats and not
SH rats. Our data indicate that chronic TS exposure in SH
rats can lead to the development of a squamous metapla-
sia that is both CK13+ and keratinised in the upper air-
ways that potentially arises from the basal cells. When
compared to human pulmonary squamous metaplasia,
this suggests key differences in the progenitor cell popula-
tions and the mechanics of epithelial repair in rat lungs
compared to human lungs. However, we cannot rule out
the possibility that due to differences in cell turnover
kinetics between rat and man, the lesions are of essentially
the same phenotype - albeit at different stages of matura-
tion. However, we would suggest that the distinct com-
partmentalisation of p63 and CK13 expression in the rat
supports the case for a distinct mucosal remodelling phe-
notype compared to man.
The presence of the squamous metaplasia in the proximal
airways also had a potential functional consequence.
There was a loss of staining in areas of squamous metapla-
sia for the epithelial proteins CC10 and surfactant D,
which are required for airway epithelial cell function. This
could indicate a change in function from secretory airway
epithelial cells, presumably to a more barrier-type func-
tion, although we have not applied any specific markers to
investigate this. A lack of staining for CC10 has also been
shown in samples of squamous metaplasia in human
bronchi [38] and in mice, the levels of CC10 in tumours
may also be indicative of the state of tumour progression
as larger carcinomas showed consistently less staining
[40]. Also, Stripp and colleagues have demonstrated that
CC10 expressing (CE) cells, including the variant CE, are
important stem cells in bronchial epithelium in mice but
when they are lost, an alternative basal cell will then serve
as a progenitor cell [41,42]. Our studies are in accordance
with these results as we have demonstrated a loss of CC10
but an increase in p63+ basal cells.
Conversely, there was an increase in the numbers of cells
staining for CC10 and surfactant D in the periphery of the
TS exposed lungs particularly type II pneumocyte around
affected bronchioles. The more diffuse staining pattern
appears to be from an increase in the numbers of resident
cells (mainly type II pneumocytes) and from infiltration
of inflammatory cells but also the presence of staining in
new cell populations. Type I pneumocytes now showed
staining for p-p38 and surfactant D. The result for p-p38
is in agreement with the complementary study to ours per-
formed by Zhong and co-workers [22], who showed by
Western blotting that there was a 3-fold increase in p-p38.
We have added to this information by further defining the
parenchyma as the compartment in which this occurs. We
have previously shown similar results in a repeat LPS chal-
lenge model [33] and we hypothesise that this altered pro-
file for proteins such as CC10 and surfactant D in the
alveolar bed is an attempt by the lung to compensate for
losses in the proximal airways and to maintain airway pat-
ency.
Within the peripheral alveolar bed compartment of TS
exposed SH rats, a number of pathological changes are
seen which are consistent with human COPD lung includ-
ing presence of mononuclear inflammatory cells, matrix
deposition and remodelling of the alveolar bed, paren-
chymal airspace enlargement and a loss of connectivity.
We have chosen to use the term airspace enlargement
rather than emphysema due to the inherent hyperinfla-
tion seen in rodents, which is often described as emphy-
sema and is considered as a pathological consequence of
the particular insult being examined. It is not known
whether the damage and remodelling in the alveolar bed
is directly due to the presence of inflammatory cells seen
within the alveolar bed or whether it is a direct effect of
the TS on the resident cells. This study showed a marginal
increase in activated caspase 3 by immunohistochemistry
and the associated study by Zhong and co-workers
showed an increase, by Western blotting, in the paren-
chyma of activated caspases 3, 8 and 9 [29]. This indicatesPage 13 of 15
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also be a mechanism that contributes to airspace enlarge-
ment. Smith and co-workers [43] used the same model to
show that a catalytic antioxidant could reduce the num-
bers of cells in the bronchoalveolar lavage fluid and
reduce pathological changes associated with TS exposure
indicating that it is the trafficking of the inflammatory
cells that is playing an important role. The results indicate
that chronic exposure to TS induces changes in the alveo-
lar bed compartment and further characterisation and
morphometric analysis of the distal airway and alveolar
bed changes are to be the focus of a subsequent paper
(Bolton et al., manuscript in preparation).
This study also highlights some intriguing differences
between rat and human airways that have not been docu-
mented before. Immunostaining for p63 was seen in the
basal cells of human airways in nearly all airways seen
regardless of size. However, in the rats, p63+ basal cells
were only seen in the larger airways. This was not due to
the lack of basal cells in smaller airways, as some basal
cells could be identified next to the basement membrane
on an H&E stained section. This suggests that the progen-
itor cell population is different in rats versus humans, par-
ticularly in the distal airways. The p63 staining in rat
squamous metaplasia also showed a graded intensity that
decreased away from the basement membrane indicating
that the basal cells are maturing and losing their p63
staining as they become squamous. Despite this, the
pathology described in this paper is centred on the com-
parison of the larger airways that have a similar p63 pro-
file. We have shown in humans that the p63-positive cell
population is sporadic compared to rat, indicating that in
humans the basal cells are either not the key drivers of the
squamous metaplasia or that their expression is lost very
rapidly and epithelium matures more quickly. Consistent
with this is a report that p63 and CK14 levels are increased
in a rat multi-layered epithelium model of Barrett's
esophagus compared to human tissue samples [44].
Involucrin, a marker of late epithelial maturation, is also
increased in COPD [6], suggesting that the squamous
metaplasia matures to a greater extent in humans than in
rats. These results highlight key differences at a molecular
level between a morphologically similar squamous meta-
plasia in humans and rats. Further studies would be
needed to elucidate whether this was a reflection of the
reversibility of the pathology as the squamous metaplasia
seen in this SH rat study will revert with time (KE Pinker-
ton, unpublished observations), but full reversion is
unlikely in humans [3,36]. It should be noted that the
conditions of the experimental procedures in rats are
tightly controlled whereas human behaviour and smok-
ing patterns are not and can have a profound influence on
the pathology of the disease.
Conclusion
We have demonstrated that exposure of SH rats to a
chronic regime of TS results in a squamous metaplasia
within the proximal airways that has functional effects in
both the proximal and the distal airways. The squamous
metaplasia was shown to have morphological similarities
to lesions found in human COPD. However, there were
key differences at the molecular level, particularly of the
basal cells, that highlight potential differences in the
mechanism by which the metaplasia arises. We also spec-
ulate whether the progenitor cell populations within the
lung are different in rats compared to humans.
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